Lunai Bioworks Inc. Lessee, Operating Lease, Liability, to be Paid, Year One
Lunai Bioworks Inc. (LNAI) had Lessee, Operating Lease, Liability, to be Paid, Year One of $364.00 thousand as of 2025-06-30, per its 10-K filed 2025-09-29.
Financial Statements › Notes › Commitment and Contingencies › Lessee, Operating Lease, Liability, to be Paid, Fiscal Year Maturity
us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths · last filed 2025-09-29
- 2025-06-30: Lessee, Operating Lease, Liability, to be Paid, Year One $364.00K.
- 2024-06-30: Lessee, Operating Lease, Liability, to be Paid, Year One $554.45K.
- 2024-03-31: Lessee, Operating Lease, Liability, to be Paid, Year One $286.25K.
- 2023-12-31: Lessee, Operating Lease, Liability, to be Paid, Year One $123.60K.
| Period end | Lessee, Operating Lease, Liability, to be Paid, Year One |
|---|---|
| 2025-06-30 | $364.00K 10-K · filed 2025-09-29 |
| 2024-06-30 | $554.45K 10-K/A · filed 2025-02-19 |
| 2024-03-31 | $286.25K 10-Q/A · filed 2025-02-19 |
| 2023-12-31 | $123.60K 10-Q · filed 2024-02-14 |
| 2023-09-30 | $185.40K 10-Q · filed 2023-11-14 |
| 2023-06-30 | $246.00K 10-K · filed 2023-10-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PMV Pharmaceuticals, Inc. (PMVP) | United States | $0.071B | -0.95 |
| TENAX THERAPEUTICS, INC. (TENX) | United States | $0.071B | -7.17 |
| PLIANT THERAPEUTICS, INC. (PLRX) | United States | $0.071B | -0.76 |
| Spero Therapeutics, Inc. (SPRO) | United States | $0.073B | 17.41 |
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| Yarrow Bioscience, Inc. (YARW) | United States | $0.070B | |
| Aldeyra Therapeutics, Inc. (ALDX) | United States | $0.074B | -5.57 |
| Connect Biopharma Holdings Ltd (CNTB) | $0.069B | -2.17 | |
| OS Therapies Inc (OSTX) | United States | $0.076B | -2.17 |
| Verrica Pharmaceuticals Inc. (VRCA) | United States | $0.076B | -3.39 |